Aufman Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Aufman Associates's JNJ Position: Q1 2026 in Review
Aufman Associates reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q1 2026, selling an estimated $44.5K and leaving 3,203 shares worth $783K. The position accounts for 0.38% of the portfolio, ranked #24.
Aufman Associates first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Aufman Associates held 3,203 shares of Johnson & Johnson worth $783K as of Q1 2026.
- Aufman Associates sold 191 Johnson & Johnson shares in Q1 2026, an estimated $44.5K.
- Johnson & Johnson made up 0.38% of Aufman Associates's portfolio in Q1 2026, its #24 holding.
- Aufman Associates first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Aufman Associates's 13F filing for Q1 2026, filed 15 May 2026.